Insider · CIK 0001362155

Douglas Earl Martin

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001362155

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-21	ALLOAllogene Therapeutics, Inc.S Sale	SVP, General Counsel	SSale	−29.7K sh	$2.12	−$63K	488,267
2026-02-02	ALLOAllogene Therapeutics, Inc.S Sale	SVP, General Counsel	SSale	−22.9K sh	$1.76	−$40.3K	564,948
2026-02-02	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, General Counsel	AAward	+539K sh	—	—	539,072
2026-02-02	ALLOAllogene Therapeutics, Inc. · Restricted Stock UnitA Award	SVP, General Counsel	AAward	+152K sh	—	—	152,480
2025-02-03	ALLOAllogene Therapeutics, Inc.S Sale	SVP, General Counsel	SSale	−6,404 sh	$1.71	−$11K	587,848
2025-01-24	ALLOAllogene Therapeutics, Inc.A Award	SVP, General Counsel	AAward	+145K sh	—	—	594,252
2025-01-24	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, General Counsel	AAward	+512K sh	—	—	512,370
2024-08-21	ALLOAllogene Therapeutics, Inc.F Tax Payment	SVP, General Counsel	FTax Payment	−28.3K sh	$2.79	−$78.8K	449,324
2024-01-25	ALLOAllogene Therapeutics, Inc.A Award	SVP, General Counsel	AAward	+41.8K sh	—	—	477,634
2024-01-25	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, General Counsel	AAward	+148K sh	—	—	147,778
2023-08-14	ALLOAllogene Therapeutics, Inc.A Award	SVP, General Counsel	AAward	+109K sh	—	—	108,958
2023-08-14	ALLOAllogene Therapeutics, Inc.A Award	SVP, General Counsel	AAward	+327K sh	—	—	435,834
2023-08-14	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SVP, General Counsel	AAward	+961K sh	—	—	960,854
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−1,400 sh	$2.33	−$3,262	47,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−6,000 sh	$2.35	−$14.1K	41,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.34	−$7,023.9	38,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−5,000 sh	$2.36	−$11.8K	33,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−1,300 sh	$2.35	−$3,055	32,217
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−400 sh	$2.35	−$940	31,817
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−2,000 sh	$2.36	−$4,720.2	29,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−5,000 sh	$2.37	−$11.9K	24,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−5,000 sh	$2.38	−$11.9K	19,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−461 sh	$2.37	−$1,093.031	19,056
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−8,000 sh	$2.35	−$18.8K	11,056
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−300 sh	$2.35	−$705	31,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−5,000 sh	$2.35	−$11.8K	53,517
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−1,100 sh	$2.32	−$2,552	52,417
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−200 sh	$2.33	−$466	52,217
2012-03-28	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,300 sh	$2.34	−$7,722.33	48,917
2012-03-27	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−5,000 sh	$2.34	−$11.7K	58,517
2012-03-26	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−1,100 sh	$2.35	−$2,585	63,517
2012-02-29	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)A Award	General Counsel	AAward	+80K sh	—	—	80,000
2011-10-14	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$3.06	−$9,166.5	57,144
2011-10-13	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.98	−$8,941.5	60,144
2011-10-12	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.99	−$8,970.9	63,144
2011-10-11	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$3.01	−$9,015.6	66,144
2011-10-10	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.97	−$8,910.6	69,144
2011-10-07	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$3.02	−$9,046.5	72,144
2011-10-06	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.99	−$8,964.9	75,144
2011-10-05	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.95	−$8,836.2	78,144
2011-10-04	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.89	−$8,678.4	81,144
2011-10-03	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−3,000 sh	$2.92	−$8,756.4	84,144
2011-01-19	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)A Award	General Counsel	AAward	+40K sh	—	—	40,000
2010-03-17	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−18K sh	—	—	0
2010-03-17	BIOMIMETIC THERAPEUTICS, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+18K sh	$3.63	+$65.3K	87,161
2010-03-17	BIOMIMETIC THERAPEUTICS, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+7,500 sh	$3.63	+$27.2K	94,661
2010-03-17	BIOMIMETIC THERAPEUTICS, INC.F Tax Payment	General Counsel	FTax Payment	−6,975 sh	$13.27	−$92.6K	87,686
2010-03-17	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−4,430 sh	$13.30	−$58.9K	83,256
2010-03-17	BIOMIMETIC THERAPEUTICS, INC.S Sale	General Counsel	SSale	−570 sh	$13.30	−$7,581.513	82,686
2010-03-17	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−7,500 sh	—	—	0

Recent filings

Accepted (ET)
Aug 254
Douglas Earl Martin0001628280-26-058920
SEC(opens sec.gov)
Feb 44
Douglas Earl Martin0001362155-26-000002
SEC(opens sec.gov)
Feb 54
Douglas Earl Martin0001737287-25-000020
SEC(opens sec.gov)
Jan 284
Douglas Earl Martin0001737287-25-000009
SEC(opens sec.gov)
Aug 234
Douglas Earl Martin0001593968-24-001096
SEC(opens sec.gov)
Jan 314
Douglas Earl Martin0001593968-24-000196
SEC(opens sec.gov)
Aug 174
Douglas Earl Martin0001593968-23-001226
SEC(opens sec.gov)
Mar 284
Douglas Earl Martin0001209191-12-020298
SEC(opens sec.gov)

Companies

Address

210 EAST GRAND AVE

SOUTH SAN FRANCISCO, CA, 94080